These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21548136)

  • 1. Bone morphogenetic protein-2 in biodegradable gelatin and β-tricalcium phosphate sponges enhances the in vivo bone-forming capability of bone marrow mesenchymal stem cells.
    Tadokoro M; Matsushima A; Kotobuki N; Hirose M; Kimura Y; Tabata Y; Hattori K; Ohgushi H
    J Tissue Eng Regen Med; 2012 Apr; 6(4):253-60. PubMed ID: 21548136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites.
    Noshi T; Yoshikawa T; Dohi Y; Ikeuchi M; Horiuchi K; Ichijima K; Sugimura M; Yonemasu K; Ohgushi H
    Artif Organs; 2001 Mar; 25(3):201-8. PubMed ID: 11284887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoinductivity of gelatin/β-tricalcium phosphate sponges loaded with different concentrations of mesenchymal stem cells and bone morphogenetic protein-2 in an equine bone defect model.
    Seo JP; Tsuzuki N; Haneda S; Yamada K; Furuoka H; Tabata Y; Sasaki N
    Vet Res Commun; 2014 Mar; 38(1):73-80. PubMed ID: 24442646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and β-tricalcium phosphate.
    Fujita N; Matsushita T; Ishida K; Sasaki K; Kubo S; Matsumoto T; Kurosaka M; Tabata Y; Kuroda R
    J Tissue Eng Regen Med; 2012 Apr; 6(4):291-8. PubMed ID: 21706776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells.
    Hanada K; Dennis JE; Caplan AI
    J Bone Miner Res; 1997 Oct; 12(10):1606-14. PubMed ID: 9333121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant growth/differentiation factor-5 (GDF-5) stimulates osteogenic differentiation of marrow mesenchymal stem cells in porous hydroxyapatite ceramic.
    Shimaoka H; Dohi Y; Ohgushi H; Ikeuchi M; Okamoto M; Kudo A; Kirita T; Yonemasu K
    J Biomed Mater Res A; 2004 Jan; 68(1):168-76. PubMed ID: 14661262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bilayer gelatin/β-tricalcium phosphate sponges loaded with mesenchymal stem cells, chondrocytes, bone morphogenetic protein-2, and platelet rich plasma on osteochondral defects of the talus in horses.
    Seo JP; Tanabe T; Tsuzuki N; Haneda S; Yamada K; Furuoka H; Tabata Y; Sasaki N
    Res Vet Sci; 2013 Dec; 95(3):1210-6. PubMed ID: 24054973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium calcium phosphate as a novel component enhances mechanical/physical properties of gelatin scaffold and osteogenic differentiation of bone marrow mesenchymal stem cells.
    Hussain A; Bessho K; Takahashi K; Tabata Y
    Tissue Eng Part A; 2012 Apr; 18(7-8):768-74. PubMed ID: 21995670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2.
    Meinel L; Hofmann S; Betz O; Fajardo R; Merkle HP; Langer R; Evans CH; Vunjak-Novakovic G; Kaplan DL
    Biomaterials; 2006 Oct; 27(28):4993-5002. PubMed ID: 16765437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a synovial flap and gelatin/β-tricalcium phosphate sponges loaded with mesenchymal stem cells, bone morphogenetic protein-2, and platelet rich plasma on equine osteochondral defects.
    Seo JP; Kambayashi Y; Itho M; Haneda S; Yamada K; Furuoka H; Tabata Y; Sasaki N
    Res Vet Sci; 2015 Aug; 101():140-3. PubMed ID: 26267104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of BMP-2 and FGF2 on the osteogenesis of bone marrow-derived mesenchymal stem cells in hindlimb-unloaded rats.
    Qian X; Zhang C; Chen G; Tang Z; Liu Q; Chen J; Tong X; Wang J
    Cell Biochem Biophys; 2014 Nov; 70(2):1127-36. PubMed ID: 24880437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium calcium phosphate/β-tricalcium phosphate incorporation into gelatin scaffold: an in vitro comparative study.
    Hussain A; Bessho K; Takahashi K; Tabata Y
    J Tissue Eng Regen Med; 2014 Nov; 8(11):919-24. PubMed ID: 22945793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.
    Marupanthorn K; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Manochantr S
    Int J Mol Med; 2017 Mar; 39(3):654-662. PubMed ID: 28204808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced regeneration of critical bone defects using a biodegradable gelatin sponge and beta-tricalcium phosphate with bone morphogenetic protein-2.
    Matsumoto G; Omi Y; Kubota E; Ozono S; Tsuzuki H; Kinoshita Y; Yamamoto M; Tabata Y
    J Biomater Appl; 2009 Nov; 24(4):327-42. PubMed ID: 18987021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro.
    Chen C; Uludağ H; Wang Z; Jiang H
    J Cell Biochem; 2012 Dec; 113(12):3672-80. PubMed ID: 22740073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Jun; 26(17):3587-96. PubMed ID: 15621249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoblastic differentiation and in vivo osteogenic activity of marrow-derived mesenchymal stem cells stimulated by Tacrolimus: experiment with rats].
    Dong J; Dai WD; Fang TL; Lin H; Uemura T
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):190-4. PubMed ID: 17425851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mesenchymal stem cells assembled with low-dose BMP-2 in a three-dimensional hybrid construct enhances posterolateral spinal fusion in syngeneic rats.
    Hu T; Abbah SA; Toh SY; Wang M; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
    Spine J; 2015 Dec; 15(12):2552-63. PubMed ID: 26342750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells.
    Hosseinkhani H; Inatsugu Y; Hiraoka Y; Inoue S; Shimokawa H; Tabata Y
    Tissue Eng; 2005; 11(9-10):1459-75. PubMed ID: 16259601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.